Report on efficacy against SARS-CoV-2
Our technology reduced the viral replication rate of the SARS-CoV-2 New Coronavirus by over 99%, in the laboratory conditions outlined in the report attached below.
Scientifically proven by ViroStatics, a prestigious international bio-pharmaceutical center specialised in research in the treatment of viral infections (www.virostatics.com).
